Module 9 Quiz

A  Bacterial cells

B  Human cells

C  All cell types

D  Fungal cells

A  Number of genes

B  Structure of chromosomes

C  Number of chromosomes

D  Presence of double-stranded DNA

A  making a cDNA from an mRNA strand.

B  unwinding and separating the double-stranded DNA.

C  adding nucleotides to primed sites of the DNA strands.

D  binding of the primers to the single-stranded DNA.

A  Addition of a deoxyribonucleotide

B  Addition of a ribonucleotide

C  Addition of a dideoxynucleotide

D  Deletion of a deoxyribonucleotide

A  Blank control

B  dTTP control

C  Positive control

D  Oligoligated control

A  Lysozyme

B  Restriction enzyme

C  Transcriptase

D  Polymerase

A  sequence of nucleotides that codes for a protein.

B  phosphate group, a ribose sugar, and nitrogen.

C  polymeric molecule composed of nucleic acids.

D  sequence of three nucleotides.

A  Hydrogen

B  Phosphate group

C  Methyl group

D  Hydroxyl group

A  hormones.

B  histones.

C  lysosomes.

D  nucleotides.

A  60%

B  20%

C  30%

D  40%

A  pattern constellation.

B  metabolic pattern.

C  toxidrome.

D  toxin effect.

A  spectrophotometry.

B  immunoassay.

C  flame ionization gas chromatography (GC).

D  HPLC.

A  The metabolic acidosis produced is caused by increased formation of formic acid by the liver during metabolism.

B  The myocardial infarction is caused by the effect on respiratory centers in the brain and eventual lack of stimulation of the heart.

C  The coma produced is caused by an immediate decrease in sensitivity to CO2 concentration through depression of respiratory centers in the brain.

D  The hepatic necrosis is caused by depletion of a substance in the liver and eventual accumulation of the oxidized metabolite.

A  [Na+] − [Cl− +  [HCO3-]

B  [HCO3-]  − [Na+ + Cl−].

C  [Na+] + [Cl− +  [HCO3-]

D  [Cl−] + [Na+ +  [HCO3-]

A  electrophoresis.

B  GC-MS.

C  a more sensitive and specific immunoassay procedure.

D  a spot test.

A  Immediately before a dose of the drug is given.

B  There is no specific time that is the best for blood collection.

C  Immediately after a dose of the drug is given.

D  At 8 AM, when liver metabolism is highest.

A  To determine drug concentrations in a pathophysiological state

B  To monitor drugs with a broad therapeutic range

C  To monitor significant drug-drug interactions

D  To check patient compliance

A  Using a single drug as opposed to multiple drugs for treatment

B  Decreased renal elimination leading to increased free drug concentration

C  Increased drug metabolism caused by central nervous system disease

D  Using a different route of administration than is typically used for that drug

A  Albumin, Lipoprotein, and α1-Glycoprotein

B  Lipoprotein

C  Albumin

D  α1-Glycoprotein

A  subtherapeutic range.

B  half-life.

C  dosing curve.

D  volume of distribution.